These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19446672)

  • 1. [Specific aspects of vaccine manufacturing].
    Speck D
    Ann Pharm Fr; 2009 May; 67(3):213-8. PubMed ID: 19446672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public vaccine manufacturing capacity in the Latin American and Caribbean region: current status and perspectives.
    Cortes Mde L; Cardoso D; Fitzgerald J; DiFabio JL
    Biologicals; 2012 Jan; 40(1):3-14. PubMed ID: 22033155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracing and control of raw materials sourcing for vaccine manufacturers.
    Faretra Peysson L
    Biologicals; 2010 May; 38(3):352-3. PubMed ID: 20335052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine manufacturing: challenges and solutions.
    Ulmer JB; Valley U; Rappuoli R
    Nat Biotechnol; 2006 Nov; 24(11):1377-83. PubMed ID: 17093488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine Manufacturing--Second Annual visiongain Conference.
    McPherson C
    IDrugs; 2010 Jul; 13(7):437-9. PubMed ID: 20582865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost of quality assurance/quality control.
    Johnson DW
    Dev Biol Stand; 1992; 79():193-200. PubMed ID: 1286758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of Continuous Manufacturing for Liposomal Drug Products.
    Worsham RD; Thomas V; Farid SS
    Biotechnol J; 2019 Feb; 14(2):e1700740. PubMed ID: 29781114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manufacturing DTaP-based combination vaccines: industrial challenges around essential public health tools.
    Vidor E; Soubeyrand B
    Expert Rev Vaccines; 2016 Dec; 15(12):1575-1582. PubMed ID: 27345296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chinese vaccine products go global: vaccine development and quality control.
    Xu M; Liang Z; Xu Y; Wang J
    Expert Rev Vaccines; 2015 May; 14(5):763-73. PubMed ID: 25697690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future supply chains enabled by continuous processing--opportunities and challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Srai JS; Badman C; Krumme M; Futran M; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):840-9. PubMed ID: 25631279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advantages of single-use technology for vaccine fill-finish operations.
    Jenness E; Walker S
    PDA J Pharm Sci Technol; 2014; 68(4):381-3. PubMed ID: 25035260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory harmonization--a vaccine industry perspective.
    Goodrich TD
    Dev Biol Stand; 1997; 90():355-61. PubMed ID: 9270864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. China's emerging vaccine industry.
    Hendriks J; Liang Y; Zeng B
    Hum Vaccin; 2010 Jul; 6(7):602-7. PubMed ID: 20523120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Veterinary vaccine development from an industrial perspective.
    Heldens JG; Patel JR; Chanter N; Ten Thij GJ; Gravendijck M; Schijns VE; Langen A; Schetters TP
    Vet J; 2008 Oct; 178(1):7-20. PubMed ID: 18313956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The business of making vaccines.
    Sheridan C
    Nat Biotechnol; 2005 Nov; 23(11):1359-66. PubMed ID: 16273061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Build a Sustainable Vaccines Industry with Synthetic Biology.
    Kitney RI; Bell J; Philp J
    Trends Biotechnol; 2021 Sep; 39(9):866-874. PubMed ID: 33431228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Regulatory Evaluation of Vaccines for Human Use.
    Baylor NW
    Methods Mol Biol; 2016; 1404():773-787. PubMed ID: 27076337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Provable Data Integrity in the Pharmaceutical Industry Based on Version Control Systems and the Blockchain.
    Steinwandter V; Herwig C
    PDA J Pharm Sci Technol; 2019; 73(4):373-390. PubMed ID: 30770485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.